0001179110-14-014708.txt : 20141001 0001179110-14-014708.hdr.sgml : 20141001 20141001164336 ACCESSION NUMBER: 0001179110-14-014708 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140929 FILED AS OF DATE: 20141001 DATE AS OF CHANGE: 20141001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTH NET INC CENTRAL INDEX KEY: 0000916085 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 954288333 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21650 OXNARD ST CITY: WOODLAND HILLS STATE: CA ZIP: 91367 BUSINESS PHONE: 8186766000 MAIL ADDRESS: STREET 1: 225 N MAIN ST CITY: PUEBLO STATE: CO ZIP: 81003 FORMER COMPANY: FORMER CONFORMED NAME: FOUNDATION HEALTH SYSTEMS INC DATE OF NAME CHANGE: 19970513 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH SYSTEMS INTERNATIONAL INC DATE OF NAME CHANGE: 19940207 FORMER COMPANY: FORMER CONFORMED NAME: HN MANAGEMENT HOLDINGS INC/DE/ DATE OF NAME CHANGE: 19931213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESCARRA VICKI B CENTRAL INDEX KEY: 0001197666 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12718 FILM NUMBER: 141133630 MAIL ADDRESS: STREET 1: AMERICA'S SECOND HARVEST STREET 2: 35 EAST WACKER DR., SUITE 2000 CITY: CHICAGO STATE: IL ZIP: 60601 4 1 edgar.xml FORM 4 - X0306 4 2014-09-29 0 0000916085 HEALTH NET INC HNT 0001197666 ESCARRA VICKI B C/O HEALTH NET, INC. 21650 OXNARD STREET WOODLAND HILLS CA 91367 1 0 0 0 Common Stock 2014-09-29 4 S 0 4468 45.69 D 17852 D Common Stock 2014-09-29 4 M 0 11600 28.08 A 29452 D Common Stock 2014-09-29 4 S 0 9500 46.46 D 19952 D Common Stock 2014-09-29 4 S 0 2100 46.69 D 17852 D Common Stock 2014-09-29 4 M 0 7366 15.3 A 25218 D Common Stock 2014-09-29 4 S 0 6266 46.47 D 18952 D Common Stock 2014-09-29 4 S 0 1100 46.70 D 17852 D Common Stock 2014-09-29 4 M 0 12859 23.51 A 30711 D Common Stock 2014-09-29 4 S 0 8928 46.43 D 21783 D Common Stock 2014-09-29 4 S 0 3931 46.65 D 17852 D Stock Option (Right to Buy) 28.08 2014-09-29 4 M 0 11600 0 D 2018-05-09 Common Stock 11600 0 D Stock Option (Right to Buy) 15.3 2014-09-29 4 M 0 7366 0 D 2016-05-22 Common Stock 7366 0 D Stock Option (Right to Buy) 23.51 2014-09-29 4 M 0 12859 0 D 2017-05-13 Common Stock 12859 0 D The sale of Common Stock by the Reporting Person, as reported on this Form 4, was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 (the "Act"), as amended. Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 9, 2008 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2008 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2008 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.64 to $46.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.64 to $46.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act. Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 22, 2009 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2009 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2009 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.66 to $46.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.67 to $46.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act. Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 13, 2010 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2010 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2010 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.58 to $46.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.58 to $46.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act. The 2008 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 9, 2008, the grant date. The 2009 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 22, 2009, the grant date. The 2010 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 13, 2010, the grant date. /s/ Vicki Escarra 2014-10-01